Professor Gary Middleton, Professor of Oncology, will be at the forefront of pioneering cancer research as ECMC Network Lead.
New study provides clues to why leukaemic stem cells not harmed by chemotherapy begin to grow and produce AML cells after treatment.
Using urinary DNA to detect circulating tumour DNA in bladder cancer patients
To mark four decades of funding, the Birmingham Cancer Research UK Clinical Trials Unit (CRCTU) held a special celebratory event in January.
Phase 2 trial found adding Bevacizumab to different chemotherapy drugs led to more patients’ tumours shrinking, which has helped to change routine UK treatment.
Screening research found that removal of RUNX1 transcription factor and target gene could lead to network collapse and cancer cell death
Professor Amos Burke has been appointed as the new Director of the Cancer Research UK Clinical Trials Unit, based at the University of Birmingham.
Birmingham researchers were invited to the UK Parliament to take part in the Breast Cancer Awareness Day, "Wear It Pink", as representatives of the Midlands.
Study found 59 cancer types that could have transcript start site switching weakness
The complex catalogue of interactions between genes that enable proper blood cell development to begin has been identified in a new study.